Seòmar agus comataidhean

The role of the Scottish Government is to provide policies, frameworks and resources to NHS Boards in order that they can deliver services that meet the needs of their local population. NHS Boards are responsible for deciding the distribution of funding that they receive from the Scottish Government across the services they manage, including the funding of cataract activity.

This year, as part of our additional £110 million investment to help NHS Boards tackle the longest waits for procedures and operations, more than £12 million has been ring-fenced for ophthalmology.

The information requested could only be obtained at disproportionate cost. The reason for this is that to locate and retrieve that information we would need to conduct a search of all correspondence received by the Scottish Government.

Under the Patient Rights (Scotland) Act 2011, an eligible patient is to start to receive agreed treatment within the 12-week Treatment Time Guarantee (TTG). Health Boards must take all reasonable steps to ensure they comply with this legislative guarantee.

However, the long-term impacts of the pandemic, as well as acute seasonal pressures and unprecedented levels of inflation across the public sector, has seen the NHS under the most severe pressure in its 77-year existence. This has affected almost all aspects of NHS care, including the number of planned care appointments and procedures the health service has been able to provide.

Our Budget will provide more than £110 million to health boards to increase capacity and address backlogs of treatment as we work towards achieving the 12 week TTG.

We have also committed to clearing all waits in all specialities over 52 weeks by March 2026.

National Records of Scotland (NRS) collects, preserves and produces information about Scotland's people and history, and makes it available to inform current and future generations. The majority of NRS records are free to access for all. Most records are original and can only be viewed in the NRS Historical Search Room.

No specific financial assistance is available to volunteers and researchers who wish to access the records of patients who died while being treated at former psychiatric hospitals.

There is no centralised public record that provides the exact number of people buried in unmarked graves in Scotland. National Records Scotland (NRS) collects data on all deaths in Scotland, but it does not publish statistics specifically on unmarked graves.

The Scottish Government does not currently have any plans in place to remember former patients of historic asylums who were buried in unmarked graves. Details of any burial carried out in a burial ground by a burial authority are recorded in the statutory burial register so that the deceased are not forgotten.

The Scottish Government commissioned a Scottish Expert Advisory Group (SEAG) to inform implementation considerations for a targeted Lung Cancer screening programme. The purpose of the SEAG was to support the work of the UK NSC Lung Task Group, and to consider outputs from the Task Group and their application in Scotland.

The Group has provided the Scottish Government with an evaluation of costs and considerations, and have estimated set up costs at approximately £36 million for a national programme. This cost accounts for the resources and equipment required. The estimated annual cost of the screening programme is between £29 million and £39 million, dependant on a number of factors including screening uptake, once the programme is fully implemented. This estimate includes the cost of staffing required across various components of the screening pathway.

The pilot announced in our Population Health Framework will support further refinement of these costs, as well as ensuring a dedicated focus on inequalities.

The Scottish Government has committed to a lung screening pilot in response to the outcomes from the Scottish Expert Advisory Group; this is expected to support the phased roll out of a national lung screening programme. A targeted lung screening programme will improve early detection, reduce health inequalities and support better outcomes for those at highest risk. The LungScot study generated valuable evidence and insights into identifying individuals at high risk of lung cancer, and its findings will help to guide the development of a national lung screening programme. A dedicated focus on some of the most deprived areas will be vital to inform the way a national programme is targeted and managed so that lung screening truly does tackle the unfair and unequal outcomes associated with lung cancer.

The Scottish Government has provided funding to Screening Oversight and Assurance Scotland (SOAS) to plan and oversee the pilot, and to begin preparations for a national roll out. A pilot will enable us to test a national delivery model, gain deeper insights into effective implementation strategies and explore alternative approaches to boost uptake and participation. It will also enable screening to begin earlier in areas experiencing the highest levels of socio-economic deprivation, as evidence shows these individuals are at higher risk of lung cancer and have higher mortality rates. We will continue collaborating with colleagues across the NHS and partner agencies to ensure the effective rollout of lung screening, while exploring ways to minimise the impact on services further along the treatment pathway. The details of the pilot are still under development and will be shared in due course.

The Scottish Government is grateful to Professor David Weller for his work on the LungScot study, which has provided valuable evidence and insights into identifying individuals at high risk of lung cancer. The findings of the study informed the work of the Scottish Expert Advisory Group for lung screening, of which Professor Weller was a valued member.

We acknowledge the importance and benefits of early diagnosis of lung screening, and recognise that evidence shows that lung screening can save lives. It is on this basis that we have announced a pilot for targeted lung screening in our Population Health Framework, published in June this year, as part of the work towards a phased roll out of a national targeted lung screening programme.

Following the UK National Screening Committee’s recommendation for a targeted lung cancer screening program, the Scottish Government established a Scottish Expert Advisory Group for lung screening to provide advice on the scoping, implementation, establishment and delivery of a targeted lung cancer screening programme within Scotland.

The group concluded that due to the complexities of rolling out a lung screening programme, which were also recognised by the UK NSC, it will take 7-10 years for a full programme to be implemented. Complexities include establishing necessary resources and infrastructure; developing a robust diagnostic pathway; and understanding the implications for wider health services, for example, as a result of incidental findings.

In our Population Health Plan, published in June, the Scottish Government announced a lung screening pilot, which will be developed by Screening Oversight and Assurance Scotland (SOAS). SOAS will also prepare for a phased implementation of targeted lung cancer screening.